These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 28638852)
1. Olfactory dysfunction in patients with primary progressive MS. Schmidt FA; Maas MB; Geran R; Schmidt C; Kunte H; Ruprecht K; Paul F; Göktas Ö; Harms L Neurol Neuroimmunol Neuroinflamm; 2017 Jul; 4(4):e369. PubMed ID: 28638852 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related]
3. Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis. Geran R; Uecker FC; Prüss H; Haeusler KG; Paul F; Ruprecht K; Harms L; Schmidt FA Front Neurol; 2019; 10():480. PubMed ID: 31156532 [No Abstract] [Full Text] [Related]
4. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]
5. Olfactory dysfunction in multiple sclerosis: association with secondary progression. Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420 [TBL] [Abstract][Full Text] [Related]
6. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis. Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999 [TBL] [Abstract][Full Text] [Related]
7. Cervical cord lesion load is associated with disability independently from atrophy in MS. Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312 [TBL] [Abstract][Full Text] [Related]
9. Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index. de Bock L; Fraussen J; Villar LM; Álvarez-Cermeño JC; Van Wijmeersch B; van Pesch V; Stinissen P; Somers V Eur J Neurol; 2016 Apr; 23(4):722-8. PubMed ID: 26706657 [TBL] [Abstract][Full Text] [Related]
10. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis. Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961 [TBL] [Abstract][Full Text] [Related]